FDASM Highlights for UM Stakeholders: Things I’m Reading

These are just a few of the things I found while I was working on the
FDASM Highlights for UM Stakeholders, pt. 1: Early Presenters as SWOT-Plus blogpost.

What If FDA Threw a Party and No One Came? BioPharma Participation in the Part 15 Social Media Meeting: http://www.eyeonfda.com/eye_on_fda/2009/11/what-if-fda-threw-a-party-and-no-one-came-biopharma-participation-in-the-part-15-social-media-meetin.html
NOTE: Evolution of the FDA’s engagement with social media in the context of the target audience.

Frydman, Gilles. #FDASM: + ca change, + c’est la meme chose. http://e-patients.net/archives/2009/11/fdasm-ca-change-cest-la-meme-chose.html
NOTE: One of the most honest, thoughtful and relevant pieces I’ve seen.

John Mack’s slides of survey results and overview of suggested best practices for social media engagement in pharma industry.

See also part two: http://www.slideshare.net/johnmackjr/social-media-rx-promotion-fda-part2

Pitts, Peter. The Caves of Caution, Complacency and Compliance. DrugWonks. http://www.drugwonks.com/blog_post/show/7051
NOTE: This is the essence of Peter’s comments as a speaker, and I really enjoyed his presentation greatly.

Pitts, Peter. The Super Bowl of Part 15 Hearings. DrugWonks. http://www.drugwonks.com/blog_post/show/7052
NOTE: Brief synopses speaker-by-speaker of highlights from the public forum.

Dose of Digital: A Sneak Preview of My FDA Social Media Hearing Testimony. http://www.doseofdigital.com/2009/11/sneak-preview-fda-social-media-hearing-testimony/

Dose of Digital: Three Things I Learned at the FDA Social Media Hearings and Three I Wish I Had. http://www.doseofdigital.com/2009/11/three-things-i-learned-at-the-fda-social-media-hearings-and-three-i-wish-i-had/

Other things I’ve found, but haven’t read or viewed yet.

The FDA Grapples with Rules for Social Media. http://www.burrillreport.com/article-1908.html

PhRMA Proposes FDA-Approved Use of Universal Safety Symbol for Branded Tweets & SE Ads. http://pharmamkting.blogspot.com/2009/11/phrma-proposes-fda-approved-use-of.html

Speaker highlights from Pixels & PIlls.

Vimeo: PN Perspectives: The FDA, Social Media and the Future of Health Care Communications. http://vimeo.com/7559619

One response to “FDASM Highlights for UM Stakeholders: Things I’m Reading

  1. Pingback: FDASM Highlights for UM Stakeholders: Most Important Links & Things You Can Do « Emerging Technologies Librarian

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s